Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinoma

David G. Bostwick, John Srigley, David Grignon, John Maksem, Peter Humphrey, Theodorus H. van der Kwast, Debashish Bose, Jay Harrison, Robert H. Young

Research output: Contribution to journalArticle

183 Citations (Scopus)

Abstract

Atypical adenomatous hyperplasia (AAH) is a localized proliferation of small glands within the prostate that may be mistaken for carcinoma. To determine the diagnostic criteria for separating AAH from carcinoma, seven observers independently evaluated 54 selected lesions from 44 transurethral resection specimens. Three patterns of glandular proliferation were observed, all arising in association with nodular hyperplasia: AAH (38 foci), atypical small acinar proliferation of uncertain significance (eight foci), and well-differentiated carcinoma (eight foci). Of 24 architectural and cytologic features evaluated, the following were useful in separating these three patterns: variation in nuclear size (14%, 22%, and 25%, respectively), mean nucleolar diameter (0.69 μm, 1.43 μm, and 1.78 μm, respectively), largest nucleolar diameter (mean, 1.66 μm, 2.71 μm, and 2.81 μm, respectively), percentage of nucleoli greater than 1 μm in diameter (17.6%, 58.1%, and 77.5%, respectively), crystalloids within suspicious glands (16%, 13%, and 75%, respectively), luminal basophilic mucinous secretions, infiltrative borders, discontinuity of the basal cell layer in AAH (compared with complete absence in carcinoma; shown with basal cell-specific anti-keratin monoclonal antibody 34βE12 immunostaining), and intact basement membrane in AAH (compared with discontinuity in carcinoma; shown with type IV collagen immunostaining). Features that could not reliably separate AAH from carcinoma included lesion shape, circumscription, multifocality, average gland size, variation in gland size and shape, nuclear shape, chromatin pattern, and amount and tinctorial quality of cytoplasm. Although the biologic significance of AAH is uncertain, its light microscopic appearance and immunophenotype allow it to be distinguished from carcinoma in most cases.

Original languageEnglish (US)
Pages (from-to)819-832
Number of pages14
JournalHuman pathology
Volume24
Issue number8
DOIs
StatePublished - Aug 1993

Fingerprint

Hyperplasia
Prostate
Carcinoma
Collagen Type IV
Keratins
Basement Membrane
Chromatin
Cytoplasm
Monoclonal Antibodies
Staining and Labeling
Light

Keywords

  • adenosis
  • atypia
  • atypical adenomatous hyperplasia
  • carcinoma
  • intraepithelial neoplasia
  • neoplasms
  • prostate

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Bostwick, D. G., Srigley, J., Grignon, D., Maksem, J., Humphrey, P., van der Kwast, T. H., ... Young, R. H. (1993). Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinoma. Human pathology, 24(8), 819-832. https://doi.org/10.1016/0046-8177(93)90131-Y

Atypical adenomatous hyperplasia of the prostate : Morphologic criteria for its distinction from well-differentiated carcinoma. / Bostwick, David G.; Srigley, John; Grignon, David; Maksem, John; Humphrey, Peter; van der Kwast, Theodorus H.; Bose, Debashish; Harrison, Jay; Young, Robert H.

In: Human pathology, Vol. 24, No. 8, 08.1993, p. 819-832.

Research output: Contribution to journalArticle

Bostwick, DG, Srigley, J, Grignon, D, Maksem, J, Humphrey, P, van der Kwast, TH, Bose, D, Harrison, J & Young, RH 1993, 'Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinoma', Human pathology, vol. 24, no. 8, pp. 819-832. https://doi.org/10.1016/0046-8177(93)90131-Y
Bostwick, David G. ; Srigley, John ; Grignon, David ; Maksem, John ; Humphrey, Peter ; van der Kwast, Theodorus H. ; Bose, Debashish ; Harrison, Jay ; Young, Robert H. / Atypical adenomatous hyperplasia of the prostate : Morphologic criteria for its distinction from well-differentiated carcinoma. In: Human pathology. 1993 ; Vol. 24, No. 8. pp. 819-832.
@article{66dbc06aadcf4e28b3e15389c46aaf3f,
title = "Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinoma",
abstract = "Atypical adenomatous hyperplasia (AAH) is a localized proliferation of small glands within the prostate that may be mistaken for carcinoma. To determine the diagnostic criteria for separating AAH from carcinoma, seven observers independently evaluated 54 selected lesions from 44 transurethral resection specimens. Three patterns of glandular proliferation were observed, all arising in association with nodular hyperplasia: AAH (38 foci), atypical small acinar proliferation of uncertain significance (eight foci), and well-differentiated carcinoma (eight foci). Of 24 architectural and cytologic features evaluated, the following were useful in separating these three patterns: variation in nuclear size (14{\%}, 22{\%}, and 25{\%}, respectively), mean nucleolar diameter (0.69 μm, 1.43 μm, and 1.78 μm, respectively), largest nucleolar diameter (mean, 1.66 μm, 2.71 μm, and 2.81 μm, respectively), percentage of nucleoli greater than 1 μm in diameter (17.6{\%}, 58.1{\%}, and 77.5{\%}, respectively), crystalloids within suspicious glands (16{\%}, 13{\%}, and 75{\%}, respectively), luminal basophilic mucinous secretions, infiltrative borders, discontinuity of the basal cell layer in AAH (compared with complete absence in carcinoma; shown with basal cell-specific anti-keratin monoclonal antibody 34βE12 immunostaining), and intact basement membrane in AAH (compared with discontinuity in carcinoma; shown with type IV collagen immunostaining). Features that could not reliably separate AAH from carcinoma included lesion shape, circumscription, multifocality, average gland size, variation in gland size and shape, nuclear shape, chromatin pattern, and amount and tinctorial quality of cytoplasm. Although the biologic significance of AAH is uncertain, its light microscopic appearance and immunophenotype allow it to be distinguished from carcinoma in most cases.",
keywords = "adenosis, atypia, atypical adenomatous hyperplasia, carcinoma, intraepithelial neoplasia, neoplasms, prostate",
author = "Bostwick, {David G.} and John Srigley and David Grignon and John Maksem and Peter Humphrey and {van der Kwast}, {Theodorus H.} and Debashish Bose and Jay Harrison and Young, {Robert H.}",
year = "1993",
month = "8",
doi = "10.1016/0046-8177(93)90131-Y",
language = "English (US)",
volume = "24",
pages = "819--832",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Atypical adenomatous hyperplasia of the prostate

T2 - Morphologic criteria for its distinction from well-differentiated carcinoma

AU - Bostwick, David G.

AU - Srigley, John

AU - Grignon, David

AU - Maksem, John

AU - Humphrey, Peter

AU - van der Kwast, Theodorus H.

AU - Bose, Debashish

AU - Harrison, Jay

AU - Young, Robert H.

PY - 1993/8

Y1 - 1993/8

N2 - Atypical adenomatous hyperplasia (AAH) is a localized proliferation of small glands within the prostate that may be mistaken for carcinoma. To determine the diagnostic criteria for separating AAH from carcinoma, seven observers independently evaluated 54 selected lesions from 44 transurethral resection specimens. Three patterns of glandular proliferation were observed, all arising in association with nodular hyperplasia: AAH (38 foci), atypical small acinar proliferation of uncertain significance (eight foci), and well-differentiated carcinoma (eight foci). Of 24 architectural and cytologic features evaluated, the following were useful in separating these three patterns: variation in nuclear size (14%, 22%, and 25%, respectively), mean nucleolar diameter (0.69 μm, 1.43 μm, and 1.78 μm, respectively), largest nucleolar diameter (mean, 1.66 μm, 2.71 μm, and 2.81 μm, respectively), percentage of nucleoli greater than 1 μm in diameter (17.6%, 58.1%, and 77.5%, respectively), crystalloids within suspicious glands (16%, 13%, and 75%, respectively), luminal basophilic mucinous secretions, infiltrative borders, discontinuity of the basal cell layer in AAH (compared with complete absence in carcinoma; shown with basal cell-specific anti-keratin monoclonal antibody 34βE12 immunostaining), and intact basement membrane in AAH (compared with discontinuity in carcinoma; shown with type IV collagen immunostaining). Features that could not reliably separate AAH from carcinoma included lesion shape, circumscription, multifocality, average gland size, variation in gland size and shape, nuclear shape, chromatin pattern, and amount and tinctorial quality of cytoplasm. Although the biologic significance of AAH is uncertain, its light microscopic appearance and immunophenotype allow it to be distinguished from carcinoma in most cases.

AB - Atypical adenomatous hyperplasia (AAH) is a localized proliferation of small glands within the prostate that may be mistaken for carcinoma. To determine the diagnostic criteria for separating AAH from carcinoma, seven observers independently evaluated 54 selected lesions from 44 transurethral resection specimens. Three patterns of glandular proliferation were observed, all arising in association with nodular hyperplasia: AAH (38 foci), atypical small acinar proliferation of uncertain significance (eight foci), and well-differentiated carcinoma (eight foci). Of 24 architectural and cytologic features evaluated, the following were useful in separating these three patterns: variation in nuclear size (14%, 22%, and 25%, respectively), mean nucleolar diameter (0.69 μm, 1.43 μm, and 1.78 μm, respectively), largest nucleolar diameter (mean, 1.66 μm, 2.71 μm, and 2.81 μm, respectively), percentage of nucleoli greater than 1 μm in diameter (17.6%, 58.1%, and 77.5%, respectively), crystalloids within suspicious glands (16%, 13%, and 75%, respectively), luminal basophilic mucinous secretions, infiltrative borders, discontinuity of the basal cell layer in AAH (compared with complete absence in carcinoma; shown with basal cell-specific anti-keratin monoclonal antibody 34βE12 immunostaining), and intact basement membrane in AAH (compared with discontinuity in carcinoma; shown with type IV collagen immunostaining). Features that could not reliably separate AAH from carcinoma included lesion shape, circumscription, multifocality, average gland size, variation in gland size and shape, nuclear shape, chromatin pattern, and amount and tinctorial quality of cytoplasm. Although the biologic significance of AAH is uncertain, its light microscopic appearance and immunophenotype allow it to be distinguished from carcinoma in most cases.

KW - adenosis

KW - atypia

KW - atypical adenomatous hyperplasia

KW - carcinoma

KW - intraepithelial neoplasia

KW - neoplasms

KW - prostate

UR - http://www.scopus.com/inward/record.url?scp=0027220464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027220464&partnerID=8YFLogxK

U2 - 10.1016/0046-8177(93)90131-Y

DO - 10.1016/0046-8177(93)90131-Y

M3 - Article

C2 - 8375853

AN - SCOPUS:0027220464

VL - 24

SP - 819

EP - 832

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 8

ER -